NCT04270773 Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT04255849 Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04210336 Clinical Trial to Evaluate Papilocare® Gel Efficacy Into Repairment of Cervical Lesions Caused by HPV Status COMPLETED Phase NA
NCT04206813 An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT04199260 Investigation to Evaluate PAPILOCARE® Gel Effect on Normalization of Cervix Cytological Alterations Caused by HPV. Status COMPLETED Phase N/A
NCT04191967 Thermocoagulation for Treatment of Precancerous Cervical Lesions Status COMPLETED Phase NA
NCT04171505 Retrospective Cohort Study of the Effectiveness of the Prophylactic Vaccine Against the Human Papilloma Virus in the Prevention of Recurrence in Women Who Have Received an Excisional Therapy by HSIL / CIN. Status UNKNOWN Phase N/A
NCT04155294 Re-Evaluation of Annual Cytology Using HPV Testing to Upgrade Prevention in Women Living With HIV Status COMPLETED Phase N/A
NCT04098744 Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3) Status RECRUITING Phase PHASE2
NCT04083196 A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years Status COMPLETED Phase PHASE1
NCT04057924 Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN Status RECRUITING Phase N/A
NCT02809352 Epidemiology of High-risk HPV Infection in Women Participating in a Pilot Screening Program for Cervical Cancer Status COMPLETED Phase N/A
NCT01824992 Recombinant Human Interferon a-2b Gel for HPV Gynecological Infections Status COMPLETED Phase PHASE2/PHASE3